lysergic acid diethylamide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwarcz, R | 1 |
| Bennett, JP | 1 |
| Coyle, JT | 1 |
1 other study available for lysergic acid diethylamide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease.
Topics: Animals; Caudate Nucleus; Disease Models, Animal; Humans; Huntington Disease; Lysergic Acid Diethyla | 1977 |